Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studies
Titel:
Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studies
Auteur:
Vélez, Patricia Jaller, Juan J. Otero Escalante, William J. García, Erika G. Rojo, Ricardo Chapman, Douglass Persand, Katherine Matiz, Giovanna A.